
NYSEIndustrialsIndustrial - Machinery
最新数据
US$16.25
−US$0.37 · -2.23%
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
前收盘价
US$16.25
−US$0.37 · -2.23%
盘前
US$16.44
+US$0.19 · +1.17%
10月13日 7:46 ET
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
43
合理估值
情绪
69
看涨
风险
59
风险偏高
动量
27
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
日内区间
当前US$16.25
52周区间
当前US$16.25
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 9.25亿 USD | 8.61亿 USD | 8.01亿 USD | 7.18亿 USD | 6.68亿 USD |
| 销货成本 | 4.87亿 USD | 4.59亿 USD | 4.44亿 USD | 4.01亿 USD | 3.84亿 USD |
| 毛利 | 4.39亿 USD | 4.02亿 USD | 3.57亿 USD | 3.17亿 USD | 2.84亿 USD |
| 研究与开发 | 3890万 USD | 3500万 USD | 3170万 USD | 3030万 USD | 3620万 USD |
| 销售、一般及管理费用 | 3.48亿 USD | 3.38亿 USD | 3.39亿 USD | 3.57亿 USD | 2.68亿 USD |
| 营业费用 | 3.87亿 USD | 3.77亿 USD | 3.78亿 USD | 6.15亿 USD | 3.53亿 USD |
| 利息收入 | 1210万 USD | 660万 USD | 480万 USD | 60万 USD | 1.46亿 USD |
| 利息支出 | 4220万 USD | 5790万 USD | 6190万 USD | 4250万 USD | 5900万 USD |
| 折旧和摊销 | 1.38亿 USD | 1.5亿 USD | 1.63亿 USD | 1.75亿 USD | 6290万 USD |
| 营业利润 | 5150万 USD | 2480万 USD | −2190万 USD | −2.98亿 USD | −6870万 USD |
| 净利润 | 2880万 USD | −3610万 USD | −9690万 USD | −2.77亿 USD | −2.23亿 USD |
公司数据更新于 2026年10月13日。
第三方分析师预期可能变化,并非 GoAI 建议。
AI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。